REVIEW article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1656862
This article is part of the Research TopicNew Mechanisms for Anti-Cancer Drugs: Volume IIView all articles
Matrine in Cancer Therapy: Antitumor Mechanisms and Nano-Delivery Strategies
Provisionally accepted
- 1Shandong University of Traditional Chinese Medicine, Jinan, China
- 2The Second Hospital of Shandong University, Jinan, China
- 3Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Cancer remains one of the leading causes of death worldwide. The severe adverse reactions and toxic side effects associated with conventional treatments such as surgery, radiotherapy, and chemotherapy pose significant challenges for researchers and clinical practitioners. These limitations have driven the pursuit of more advanced and effective therapeutic approaches. In recent years, natural products have attracted considerable attention in the field of disease treatment and have become an important source for new drug development. Matrine, a major active component of the traditional medicinal plant Sophora flavescens, exhibits a broad range of pharmacological activities, particularly notable antitumor effects. Its antitumor mechanisms include the induction of apoptosis, autophagy, and ferroptosis in tumor cells, as well as the inhibition of tumor cell proliferation, migration, and invasion. With the continuous advancement of therapeutic technologies and the emergence of novel drug delivery strategies, the integration of natural products into cancer therapy has gained renewed significance in the context of innovative delivery systems. Based on this, the present review comprehensively discusses and analyzes the antitumor mechanisms of matrine and its application in nano-delivery systems, highlighting their progress and potential in major disease intervention strategies. This provides new insights for the development and application of advanced drug delivery strategies and technologies in both basic and clinical pharmaceutical research.
Keywords: matrine, tumor, Nano-delivery system, Mechanism, therapy
Received: 30 Jun 2025; Accepted: 26 Aug 2025.
Copyright: © 2025 Meng, cui, Li, shang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Dandan Meng, Shandong University of Traditional Chinese Medicine, Jinan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.